ON-TIME ENROLLMENT FEASIBILITY
The upfront investment of time and medical expertise into each feasibility assessment underlies PSI’s patient enrollment success in clinical trials.
For the majority of studies, where competition for patients and complexity of design are leading characteristics, we apply our years of experience to determine the best sites and countries for each study.
We give every project a thorough assessment through our dedicated, full-time Feasibility Department. Our dedicated professionals determine clinical trial feasibility for each of the following criterion:
- Medical feasibility
- Clinical feasibility
- Logistical feasibility
- Regulatory feasibility
With people located in 11 countries throughout North America, Europe, Asia, and Latin America being led by our team of internal medical doctors, laboratory experts, imaging specialists, logisticians, pharmacy and regulatory experts, PSI predicts accurate dates for the enrollment of the first and last patients.
In recent years, our specialists have conducted over 2,000+ feasibility assessments for studies in 50+ countries. These assessments cover, but are not restricted to, evaluation of the target population availability and factors that limit it, standards of care, competitive studies, regulatory climates and the need to engage particular Key Opinion Leaders into the study. We weigh all of these factors before making recommendations.
Our value-added feasibility assessments for regional or global programs provide our sponsors with the best choice of sites and geography, ensuring predictable and accurate enrollment projections.
Please contact PSI to learn how the accuracy of feasibility can help you achieve your study goals.